Loading…
External validity of randomised controlled trials in asthma: to whom do the results of the trials apply?
Background: Asthma is a heterogeneous disease with a wide range of clinical phenotypes, not all of which may be encompassed in the subjects included in randomised controlled trials (RCTs). This makes it difficult for clinicians to know to what extent the evidence derived from RCTs applies to a given...
Saved in:
Published in: | Thorax 2007-03, Vol.62 (3), p.219-223 |
---|---|
Main Authors: | , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-b522t-d5537a82850c08055a19688aaec184f9d81a54756c214ed10e988aac59d84b663 |
---|---|
cites | |
container_end_page | 223 |
container_issue | 3 |
container_start_page | 219 |
container_title | Thorax |
container_volume | 62 |
creator | Travers, Justin Marsh, Suzanne Williams, Mathew Weatherall, Mark Caldwell, Brent Shirtcliffe, Philippa Aldington, Sarah Beasley, Richard |
description | Background: Asthma is a heterogeneous disease with a wide range of clinical phenotypes, not all of which may be encompassed in the subjects included in randomised controlled trials (RCTs). This makes it difficult for clinicians to know to what extent the evidence derived from RCTs applies to a given patient. Aim: To calculate the proportion of individuals with asthma who would have been eligible for the major asthma RCTs from the data of a random community survey of respiratory health. Methods: A postal survey was sent to 3500 randomly selected individuals aged 25–75 years. Respondents were invited to complete a detailed respiratory questionnaire and pulmonary function testing. Participants with current asthma were assessed against the eligibility criteria of the 17 major asthma RCTs cited in the Global Initiative for Asthma (GINA) guidelines. Findings: A total of 749 participants completed the full survey, of whom 179 had current asthma. A median 4% of participants with current asthma (range 0–36%) met the eligibility criteria for the included RCTs. A median 6% (range 0–43%) of participants with current asthma on treatment met the eligibility criteria. Interpretation: This study shows that the major asthma RCTs on which the GINA guidelines are based may have limited external validity as they have been performed on highly selected patient populations. Most of the participants with current asthma on treatment in the community would not have been eligible for these RCTs. |
doi_str_mv | 10.1136/thx.2006.066837 |
format | article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2117157</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>70222261</sourcerecordid><originalsourceid>FETCH-LOGICAL-b522t-d5537a82850c08055a19688aaec184f9d81a54756c214ed10e988aac59d84b663</originalsourceid><addsrcrecordid>eNqFkUtv1DAUhS0EokNhzQ5ZQnSBlKmdxI90AaqiFpBGZcFjwcbyOA7x4MSD7ZSZf4-jRC2wwRv76nw-uvceAJ5jtMa4oOexO6xzhOgaUcoL9gCscEl5VuQVfQhWCJUoowWjJ-BJCDuEEMeYPQYnmGFEGKtWoLs6RO0HaeGttKYx8QhdC70cGteboBuo3BC9szY9ozfSBmgGKEPsenkBo4O_OtfDxsHYaeh1GG0Mk8NULrzc7-3x7VPwqE2Vfrbcp-DL9dXn-n22-fjuQ325ybYkz2PWEFIwyXNOkEIcESJxRTmXUivMy7ZqOJakZISqHJe6wUhXk6pIUsotpcUpeDP77sdtrxulU_vSir03vfRH4aQRfyuD6cR3dyvytBpMWDI4Wwy8-znqEEVahNLWykG7MQiG8nQoTuDLf8CdG6dVBoEZx4xShnmizmdKeReC1-1dKxiJKUORMhRThmLOMP148ecE9_wSWgJeLYAMSto2paVMuOc4KSrMUOKymTMh6sOdLv0PQVnBiLj5WovNpxtWX9ffRJ741zO_7Xf_7fI30QPB1Q</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1781766718</pqid></control><display><type>article</type><title>External validity of randomised controlled trials in asthma: to whom do the results of the trials apply?</title><source>PubMed Central Free</source><creator>Travers, Justin ; Marsh, Suzanne ; Williams, Mathew ; Weatherall, Mark ; Caldwell, Brent ; Shirtcliffe, Philippa ; Aldington, Sarah ; Beasley, Richard</creator><creatorcontrib>Travers, Justin ; Marsh, Suzanne ; Williams, Mathew ; Weatherall, Mark ; Caldwell, Brent ; Shirtcliffe, Philippa ; Aldington, Sarah ; Beasley, Richard</creatorcontrib><description>Background: Asthma is a heterogeneous disease with a wide range of clinical phenotypes, not all of which may be encompassed in the subjects included in randomised controlled trials (RCTs). This makes it difficult for clinicians to know to what extent the evidence derived from RCTs applies to a given patient. Aim: To calculate the proportion of individuals with asthma who would have been eligible for the major asthma RCTs from the data of a random community survey of respiratory health. Methods: A postal survey was sent to 3500 randomly selected individuals aged 25–75 years. Respondents were invited to complete a detailed respiratory questionnaire and pulmonary function testing. Participants with current asthma were assessed against the eligibility criteria of the 17 major asthma RCTs cited in the Global Initiative for Asthma (GINA) guidelines. Findings: A total of 749 participants completed the full survey, of whom 179 had current asthma. A median 4% of participants with current asthma (range 0–36%) met the eligibility criteria for the included RCTs. A median 6% (range 0–43%) of participants with current asthma on treatment met the eligibility criteria. Interpretation: This study shows that the major asthma RCTs on which the GINA guidelines are based may have limited external validity as they have been performed on highly selected patient populations. Most of the participants with current asthma on treatment in the community would not have been eligible for these RCTs.</description><identifier>ISSN: 0040-6376</identifier><identifier>EISSN: 1468-3296</identifier><identifier>DOI: 10.1136/thx.2006.066837</identifier><identifier>PMID: 17105779</identifier><identifier>CODEN: THORA7</identifier><language>eng</language><publisher>London: BMJ Publishing Group Ltd and British Thoracic Society</publisher><subject>Adult ; Aged ; Asthma ; Asthma - therapy ; Biological and medical sciences ; chronic obstructive pulmonary disease ; Chronic obstructive pulmonary disease, asthma ; Clinical trials ; COPD ; Decision making ; Female ; FEV1 ; forced expiratory volume in 1 s ; GINA ; Global Initiative for Asthma ; Humans ; Male ; Medical sciences ; Middle Aged ; Pneumology ; Questionnaires ; randomised controlled trial ; Randomized Controlled Trials as Topic - standards ; RCT ; Reproducibility of Results ; Respiratory Function Tests - methods ; Response rates</subject><ispartof>Thorax, 2007-03, Vol.62 (3), p.219-223</ispartof><rights>Copyright 2007 Thorax</rights><rights>2007 INIST-CNRS</rights><rights>Copyright: 2007 Copyright 2007 Thorax</rights><rights>Copyright © 2007 BMJ Publishing Group Ltd and British Thoracic Society.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-b522t-d5537a82850c08055a19688aaec184f9d81a54756c214ed10e988aac59d84b663</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC2117157/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC2117157/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=18539170$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17105779$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Travers, Justin</creatorcontrib><creatorcontrib>Marsh, Suzanne</creatorcontrib><creatorcontrib>Williams, Mathew</creatorcontrib><creatorcontrib>Weatherall, Mark</creatorcontrib><creatorcontrib>Caldwell, Brent</creatorcontrib><creatorcontrib>Shirtcliffe, Philippa</creatorcontrib><creatorcontrib>Aldington, Sarah</creatorcontrib><creatorcontrib>Beasley, Richard</creatorcontrib><title>External validity of randomised controlled trials in asthma: to whom do the results of the trials apply?</title><title>Thorax</title><addtitle>Thorax</addtitle><description>Background: Asthma is a heterogeneous disease with a wide range of clinical phenotypes, not all of which may be encompassed in the subjects included in randomised controlled trials (RCTs). This makes it difficult for clinicians to know to what extent the evidence derived from RCTs applies to a given patient. Aim: To calculate the proportion of individuals with asthma who would have been eligible for the major asthma RCTs from the data of a random community survey of respiratory health. Methods: A postal survey was sent to 3500 randomly selected individuals aged 25–75 years. Respondents were invited to complete a detailed respiratory questionnaire and pulmonary function testing. Participants with current asthma were assessed against the eligibility criteria of the 17 major asthma RCTs cited in the Global Initiative for Asthma (GINA) guidelines. Findings: A total of 749 participants completed the full survey, of whom 179 had current asthma. A median 4% of participants with current asthma (range 0–36%) met the eligibility criteria for the included RCTs. A median 6% (range 0–43%) of participants with current asthma on treatment met the eligibility criteria. Interpretation: This study shows that the major asthma RCTs on which the GINA guidelines are based may have limited external validity as they have been performed on highly selected patient populations. Most of the participants with current asthma on treatment in the community would not have been eligible for these RCTs.</description><subject>Adult</subject><subject>Aged</subject><subject>Asthma</subject><subject>Asthma - therapy</subject><subject>Biological and medical sciences</subject><subject>chronic obstructive pulmonary disease</subject><subject>Chronic obstructive pulmonary disease, asthma</subject><subject>Clinical trials</subject><subject>COPD</subject><subject>Decision making</subject><subject>Female</subject><subject>FEV1</subject><subject>forced expiratory volume in 1 s</subject><subject>GINA</subject><subject>Global Initiative for Asthma</subject><subject>Humans</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Pneumology</subject><subject>Questionnaires</subject><subject>randomised controlled trial</subject><subject>Randomized Controlled Trials as Topic - standards</subject><subject>RCT</subject><subject>Reproducibility of Results</subject><subject>Respiratory Function Tests - methods</subject><subject>Response rates</subject><issn>0040-6376</issn><issn>1468-3296</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><recordid>eNqFkUtv1DAUhS0EokNhzQ5ZQnSBlKmdxI90AaqiFpBGZcFjwcbyOA7x4MSD7ZSZf4-jRC2wwRv76nw-uvceAJ5jtMa4oOexO6xzhOgaUcoL9gCscEl5VuQVfQhWCJUoowWjJ-BJCDuEEMeYPQYnmGFEGKtWoLs6RO0HaeGttKYx8QhdC70cGteboBuo3BC9szY9ozfSBmgGKEPsenkBo4O_OtfDxsHYaeh1GG0Mk8NULrzc7-3x7VPwqE2Vfrbcp-DL9dXn-n22-fjuQ325ybYkz2PWEFIwyXNOkEIcESJxRTmXUivMy7ZqOJakZISqHJe6wUhXk6pIUsotpcUpeDP77sdtrxulU_vSir03vfRH4aQRfyuD6cR3dyvytBpMWDI4Wwy8-znqEEVahNLWykG7MQiG8nQoTuDLf8CdG6dVBoEZx4xShnmizmdKeReC1-1dKxiJKUORMhRThmLOMP148ecE9_wSWgJeLYAMSto2paVMuOc4KSrMUOKymTMh6sOdLv0PQVnBiLj5WovNpxtWX9ffRJ741zO_7Xf_7fI30QPB1Q</recordid><startdate>20070301</startdate><enddate>20070301</enddate><creator>Travers, Justin</creator><creator>Marsh, Suzanne</creator><creator>Williams, Mathew</creator><creator>Weatherall, Mark</creator><creator>Caldwell, Brent</creator><creator>Shirtcliffe, Philippa</creator><creator>Aldington, Sarah</creator><creator>Beasley, Richard</creator><general>BMJ Publishing Group Ltd and British Thoracic Society</general><general>BMJ</general><general>BMJ Publishing Group LTD</general><general>BMJ Group</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>BTHHO</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20070301</creationdate><title>External validity of randomised controlled trials in asthma: to whom do the results of the trials apply?</title><author>Travers, Justin ; Marsh, Suzanne ; Williams, Mathew ; Weatherall, Mark ; Caldwell, Brent ; Shirtcliffe, Philippa ; Aldington, Sarah ; Beasley, Richard</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b522t-d5537a82850c08055a19688aaec184f9d81a54756c214ed10e988aac59d84b663</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Asthma</topic><topic>Asthma - therapy</topic><topic>Biological and medical sciences</topic><topic>chronic obstructive pulmonary disease</topic><topic>Chronic obstructive pulmonary disease, asthma</topic><topic>Clinical trials</topic><topic>COPD</topic><topic>Decision making</topic><topic>Female</topic><topic>FEV1</topic><topic>forced expiratory volume in 1 s</topic><topic>GINA</topic><topic>Global Initiative for Asthma</topic><topic>Humans</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Pneumology</topic><topic>Questionnaires</topic><topic>randomised controlled trial</topic><topic>Randomized Controlled Trials as Topic - standards</topic><topic>RCT</topic><topic>Reproducibility of Results</topic><topic>Respiratory Function Tests - methods</topic><topic>Response rates</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Travers, Justin</creatorcontrib><creatorcontrib>Marsh, Suzanne</creatorcontrib><creatorcontrib>Williams, Mathew</creatorcontrib><creatorcontrib>Weatherall, Mark</creatorcontrib><creatorcontrib>Caldwell, Brent</creatorcontrib><creatorcontrib>Shirtcliffe, Philippa</creatorcontrib><creatorcontrib>Aldington, Sarah</creatorcontrib><creatorcontrib>Beasley, Richard</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central</collection><collection>BMJ Journals</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Thorax</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Travers, Justin</au><au>Marsh, Suzanne</au><au>Williams, Mathew</au><au>Weatherall, Mark</au><au>Caldwell, Brent</au><au>Shirtcliffe, Philippa</au><au>Aldington, Sarah</au><au>Beasley, Richard</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>External validity of randomised controlled trials in asthma: to whom do the results of the trials apply?</atitle><jtitle>Thorax</jtitle><addtitle>Thorax</addtitle><date>2007-03-01</date><risdate>2007</risdate><volume>62</volume><issue>3</issue><spage>219</spage><epage>223</epage><pages>219-223</pages><issn>0040-6376</issn><eissn>1468-3296</eissn><coden>THORA7</coden><abstract>Background: Asthma is a heterogeneous disease with a wide range of clinical phenotypes, not all of which may be encompassed in the subjects included in randomised controlled trials (RCTs). This makes it difficult for clinicians to know to what extent the evidence derived from RCTs applies to a given patient. Aim: To calculate the proportion of individuals with asthma who would have been eligible for the major asthma RCTs from the data of a random community survey of respiratory health. Methods: A postal survey was sent to 3500 randomly selected individuals aged 25–75 years. Respondents were invited to complete a detailed respiratory questionnaire and pulmonary function testing. Participants with current asthma were assessed against the eligibility criteria of the 17 major asthma RCTs cited in the Global Initiative for Asthma (GINA) guidelines. Findings: A total of 749 participants completed the full survey, of whom 179 had current asthma. A median 4% of participants with current asthma (range 0–36%) met the eligibility criteria for the included RCTs. A median 6% (range 0–43%) of participants with current asthma on treatment met the eligibility criteria. Interpretation: This study shows that the major asthma RCTs on which the GINA guidelines are based may have limited external validity as they have been performed on highly selected patient populations. Most of the participants with current asthma on treatment in the community would not have been eligible for these RCTs.</abstract><cop>London</cop><pub>BMJ Publishing Group Ltd and British Thoracic Society</pub><pmid>17105779</pmid><doi>10.1136/thx.2006.066837</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0040-6376 |
ispartof | Thorax, 2007-03, Vol.62 (3), p.219-223 |
issn | 0040-6376 1468-3296 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2117157 |
source | PubMed Central Free |
subjects | Adult Aged Asthma Asthma - therapy Biological and medical sciences chronic obstructive pulmonary disease Chronic obstructive pulmonary disease, asthma Clinical trials COPD Decision making Female FEV1 forced expiratory volume in 1 s GINA Global Initiative for Asthma Humans Male Medical sciences Middle Aged Pneumology Questionnaires randomised controlled trial Randomized Controlled Trials as Topic - standards RCT Reproducibility of Results Respiratory Function Tests - methods Response rates |
title | External validity of randomised controlled trials in asthma: to whom do the results of the trials apply? |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T02%3A12%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=External%20validity%20of%20randomised%20controlled%20trials%20in%20asthma:%20to%20whom%20do%20the%20results%20of%20the%20trials%20apply?&rft.jtitle=Thorax&rft.au=Travers,%20Justin&rft.date=2007-03-01&rft.volume=62&rft.issue=3&rft.spage=219&rft.epage=223&rft.pages=219-223&rft.issn=0040-6376&rft.eissn=1468-3296&rft.coden=THORA7&rft_id=info:doi/10.1136/thx.2006.066837&rft_dat=%3Cproquest_pubme%3E70222261%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-b522t-d5537a82850c08055a19688aaec184f9d81a54756c214ed10e988aac59d84b663%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1781766718&rft_id=info:pmid/17105779&rfr_iscdi=true |